Armata - Aset Bersih saben Siji Saham ARMP

Logo grafis Armata Pharmaceuticals (ARMP)

The commercial potential of Armata Pharmaceuticals (ARMP) is limited by the trial stage, and therefore the current metric stands at -6.16. The company is valued by the scientific community for its pursuit of methods to combat resistant pathogens. This price chart available on the page complements data regarding partnerships with laboratories that help accelerate the market launch of new bacteriophage products.

Armata Pharmaceuticals Inc (ARMP): Nilai Buku Saham saka 04.07.2022 nganti 27.10.2026

armatapharma.com - rincian analitis lan metrik utama (ARMP)

- rega lan prakiraan konsensus rega:
Bagan rega Armata Pharma|ARMP - Target konsensus
- data kapitalisasi pasar:
Nilai pasar Armata Pharmaceuticals, Inc.|ARMP - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Armata Pharmaceuticals|ARMP - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku armatapharma.com|ARMP - Nilai Agregat Aset
- data utang lan likuiditas:
Total Utang marang Modal Armata Pharmaceuticals|ARMP - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Armata Pharmaceuticals, Inc.|ARMP - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Armata Pharmaceuticals, Inc.
Pambiji fundamental perusahaan:Armata Pharma - ARMP
Produk sing diprodhuksi Armata Pharmaceuticals, Inc.

Book value per share determines the portion of equity available to the shareholder after all liabilities are settled, allowing for an assessment of the business's intrinsic value. By analyzing this key book value metric, an investor can track the net asset dynamics of Armata Pharmaceuticals (ARMP), which, during its R&D scaling phase and bacteriophage clinical trials, depends directly on the volume of funding raised from funds.

Pesaing Armata Pharmaceuticals (ARMP)

ACXP: Aset Bersih saben Siji Saham